Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San ...

GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...

Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth ...

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: ...

Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...

The Company announces that on 6 January 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1314 pence per share. Further details are set out below: ...

Gold prices moved to the downside during trading on Monday, extending the pullback seen during last Friday's session. Gold for ...

The Taiwan stock market has climbed higher in consecutive trading days, accelerating more than 700 points or 2.9 percent along the ...

The Hong Kong stock market has alternated between positive and negative finishes through the last four trading days since the end of ...

After moving to the upside early in the session, the price of crude oil gave back ground over the course of the trading day on ...